Bausch Health Companies | VRX - Assets

Stock Price
8.28
Daily Change
0.07 0.85%
Monthly
4.02%
Yearly
-23.26%
Q1 Forecast
8.16

Bausch Health Companies reported $26.37B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Amgen USD 90.59B 445M Dec/2025
ANI Pharmaceuticals USD 1.41B 65.15M Sep/2025
Aurora Cannabis CAD 756.86M 80.98M Sep/2025
Bausch Health Companies USD 26.37B 458M Dec/2025
Biogen USD 29.44B 232M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Canopy Growth CAD 1.07B 165.17M Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Danaher USD 83.46B 3.57B Dec/2025
Drreddys Laboratories INR 6.26B 161.9M Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
Nektar Therapeutics USD 301.35M 93.81M Sep/2025
Novo Nordisk DKK 542.9B 30.61B Dec/2025
Pacira USD 1.3B 239.68M Sep/2025
Perrigo USD 10.08B 10.1M Sep/2025
Phibro Animal Health USD 1.41B 20.03M Dec/2025
Prestige Brands USD 3.49B 52.46M Dec/2025
Supernus Pharmaceuticals USD 1.42B 37.35M Sep/2025
Vertex Pharmaceuticals USD 25.64B 780.7M Dec/2025
Zoetis USD 15.47B 308M Dec/2025